Persistence of fixed-dose combinations including dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes in Japan: analysis using a claims database

Key Points

• To evaluate the persistence of fixed-dose combinations including DPP-4 inhibitors among patients with type 2 diabetes.
• Analysis of claims database for treatment persistence
• Focus on patients with type 2 diabetes in Japan
• Real-world evaluation of medication adherence
• Insight into adherence levels to fixed-dose combinations
• Identification of current treatment practices in type 2 diabetes